These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38519054)

  • 1. Targeting pediatric cancers via T-cell recognition of the monomorphic MHC class I-related protein MR1.
    Cornel AM; van der Sman L; van Dinter JT; Arrabito M; Dunnebach E; van Hoesel M; Kluiver TA; Lopes AP; Dautzenberg NMM; Dekker L; van Rijn JM; van den Beemt DAMH; Buhl JL; du Chatinier A; Barneh F; Lu Y; Lo Nigro L; Krippner-Heidenreich A; Sebestyén Z; Kuball J; Hulleman E; Drost J; van Heesch S; Heidenreich OT; Peng WC; Nierkens S
    J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38519054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deaza-modification of MR1 ligands modulates recognition by MR1-restricted T cells.
    Jin H; Ladd NA; Peev AM; Swarbrick GM; Cansler M; Null M; Boughter CT; McMurtrey C; Nilsen A; Dobos KM; Hildebrand WH; Lewinsohn DA; Adams EJ; Lewinsohn DM; Harriff MJ
    Sci Rep; 2022 Dec; 12(1):22539. PubMed ID: 36581641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide CRISPR-Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1.
    Crowther MD; Dolton G; Legut M; Caillaud ME; Lloyd A; Attaf M; Galloway SAE; Rius C; Farrell CP; Szomolay B; Ager A; Parker AL; Fuller A; Donia M; McCluskey J; Rossjohn J; Svane IM; Phillips JD; Sewell AK
    Nat Immunol; 2020 Feb; 21(2):178-185. PubMed ID: 31959982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR1-restricted T cells: the new dawn of cancer immunotherapy.
    Wang Z; Wang M; Chen J; Zhang L; Zhang L; Yu L
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33185693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR1-Restricted T Cells Are Unprecedented Cancer Fighters.
    Vacchini A; Chancellor A; Spagnuolo J; Mori L; De Libero G
    Front Immunol; 2020; 11():751. PubMed ID: 32411144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell receptor diversity, specificity and promiscuity of functionally heterogeneous human MR1-restricted T cells.
    Lepore M; Lewinsohn DA; Lewinsohn DM
    Mol Immunol; 2021 Feb; 130():64-68. PubMed ID: 33360378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functionally diverse human T cells recognize non-microbial antigens presented by MR1.
    Lepore M; Kalinichenko A; Calogero S; Kumar P; Paleja B; Schmaler M; Narang V; Zolezzi F; Poidinger M; Mori L; De Libero G
    Elife; 2017 May; 6():. PubMed ID: 28518056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A molecular basis underpinning the T cell receptor heterogeneity of mucosal-associated invariant T cells.
    Eckle SB; Birkinshaw RW; Kostenko L; Corbett AJ; McWilliam HE; Reantragoon R; Chen Z; Gherardin NA; Beddoe T; Liu L; Patel O; Meehan B; Fairlie DP; Villadangos JA; Godfrey DI; Kjer-Nielsen L; McCluskey J; Rossjohn J
    J Exp Med; 2014 Jul; 211(8):1585-600. PubMed ID: 25049336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen Recognition by MR1-Reactive T Cells; MAIT Cells, Metabolites, and Remaining Mysteries.
    Corbett AJ; Awad W; Wang H; Chen Z
    Front Immunol; 2020; 11():1961. PubMed ID: 32973800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recognition of the antigen-presenting molecule MR1 by a Vδ3
    Rice MT; von Borstel A; Chevour P; Awad W; Howson LJ; Littler DR; Gherardin NA; Le Nours J; Giles EM; Berry R; Godfrey DI; Davey MS; Rossjohn J; Gully BS
    Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34845016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR1 antigen presentation to MAIT cells and other MR1-restricted T cells.
    McWilliam HEG; Villadangos JA
    Nat Rev Immunol; 2024 Mar; 24(3):178-192. PubMed ID: 37773272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The burgeoning role of MR1-restricted T-cells in infection, cancer and autoimmune disease.
    Crowther MD; Sewell AK
    Curr Opin Immunol; 2021 Apr; 69():10-17. PubMed ID: 33434741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR1, an immunological periscope of cellular metabolism.
    Chancellor A; Vacchini A; De Libero G
    Int Immunol; 2022 Feb; 34(3):141-147. PubMed ID: 34718585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Divergent HLA variations and heterogeneous expression but recurrent HLA loss-of- heterozygosity and common
    Lim WC; Marques Da Costa ME; Godefroy K; Jacquet E; Gragert L; Rondof W; Marchais A; Nhiri N; Dalfovo D; Viard M; Labaied N; Khan AM; Dessen P; Romanel A; Pasqualini C; Schleiermacher G; Carrington M; Zitvogel L; Scoazec JY; Geoerger B; Salmon J
    Front Immunol; 2023; 14():1265469. PubMed ID: 38318504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postnatal Expansion, Maturation, and Functionality of MR1T Cells in Humans.
    Swarbrick GM; Gela A; Cansler ME; Null MD; Duncan RB; Nemes E; Shey M; Nsereko M; Mayanja-Kizza H; Kiguli S; Koh J; Hanekom WA; Hatherill M; Lancioni C; Lewinsohn DM; Scriba TJ; Lewinsohn DA
    Front Immunol; 2020; 11():556695. PubMed ID: 33042140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual TCR-α Expression on Mucosal-Associated Invariant T Cells as a Potential Confounder of TCR Interpretation.
    Suliman S; Kjer-Nielsen L; Iwany SK; Lopez Tamara K; Loh L; Grzelak L; Kedzierska K; Ocampo TA; Corbett AJ; McCluskey J; Rossjohn J; León SR; Calderon R; Lecca-Garcia L; Murray MB; Moody DB; Van Rhijn I
    J Immunol; 2022 Mar; 208(6):1389-1395. PubMed ID: 35246495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential antigenic requirements by diverse MR1-restricted T cells.
    Seneviratna R; Redmond SJ; McWilliam HE; Reantragoon R; Villadangos JA; McCluskey J; Godfrey DI; Gherardin NA
    Immunol Cell Biol; 2022 Feb; 100(2):112-126. PubMed ID: 34940995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Covering All the Bases: Complementary MR1 Antigen Presentation Pathways Sample Diverse Antigens and Intracellular Compartments.
    Kulicke C; Karamooz E; Lewinsohn D; Harriff M
    Front Immunol; 2020; 11():2034. PubMed ID: 32983150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The P5-type ATPase ATP13A1 modulates major histocompatibility complex I-related protein 1 (MR1)-mediated antigen presentation.
    Kulicke CA; De Zan E; Hein Z; Gonzalez-Lopez C; Ghanwat S; Veerapen N; Besra GS; Klenerman P; Christianson JC; Springer S; Nijman SM; Cerundolo V; Salio M
    J Biol Chem; 2022 Feb; 298(2):101542. PubMed ID: 34968463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal-associated invariant T cell receptor recognition of small molecules presented by MR1.
    Awad W; Le Nours J; Kjer-Nielsen L; McCluskey J; Rossjohn J
    Immunol Cell Biol; 2018 Jul; 96(6):588-597. PubMed ID: 29393543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.